Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125,752 | -91,373 | -48,767 | -22,215 | -59,456 |
| Depreciation Amortization | 1 | 1 | 1 | 1 | 4 |
| Accounts payable and accrued liabilities | 2,846 | 4,362 | 2,109 | -264 | 7,824 |
| Other Working Capital | -7,865 | 3,891 | 707 | 48 | 10,850 |
| Other Operating Activity | 38,896 | 28,906 | 12,653 | 6,345 | 12,970 |
| Operating Cash Flow | $-91,873 | $-54,213 | $-33,297 | $-16,086 | $-27,809 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -54,118 | 37,065 | 9,554 | 36,129 | -34,448 |
| PPE Investments | N/A | N/A | N/A | -20,664 | N/A |
| Investing Cash Flow | $-54,118 | $37,065 | $9,554 | $15,466 | $-34,448 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 187,940 | 26,102 | 25,917 | 468 | 28,584 |
| Other Financing Activity | 0 | 0 | 0 | 1,461 | -110 |
| Financing Cash Flow | $187,940 | $26,102 | $25,917 | $1,928 | $28,473 |
| Beginning Cash Position | 2,495 | 2,495 | 2,495 | 2,495 | 36,279 |
| End Cash Position | 44,443 | 11,449 | 4,669 | 3,804 | 2,495 |
| Net Cash Flow | $41,948 | $8,954 | $2,174 | $1,309 | $-33,783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -91,873 | -54,213 | -33,297 | -16,086 | -27,809 |
| Capital Expenditure | N/A | N/A | N/A | -20,664 | N/A |
| Free Cash Flow | -91,873 | -54,213 | -33,297 | -36,749 | -27,809 |